Vancomycin use in pediatric hematology-oncology patients

Citation
Ha. Hopkins et al., Vancomycin use in pediatric hematology-oncology patients, INFECT CONT, 21(1), 2000, pp. 48-50
Citations number
10
Categorie Soggetti
Envirnomentale Medicine & Public Health
Journal title
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
ISSN journal
0899823X → ACNP
Volume
21
Issue
1
Year of publication
2000
Pages
48 - 50
Database
ISI
SICI code
0899-823X(200001)21:1<48:VUIPHP>2.0.ZU;2-6
Abstract
A cross-sectional study was performed of pediatric hematology-oncology pati ents who received vancomycin; use was compared to the Centers for Disease C ontrol and Prevention (CDC) recommendations for vancomycin use. Thirty-seve n patients received 308 doses of vancomycin. All patients initially receive d vancomycin as empirical therapy; 100% of this use was not consistent with the CDC recommendations (Infect Central Hosp Epidemiol 2000; 21:48-50).